Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04371159 · ClinicalTrials.gov registry record · NA

A Comparative, Controlled Study to Evaluate the Clinical Accuracy of the Velieve U.S. UTI Urine Analysis Test System

A NA study, sponsored by Healthy.io.

Completed
Registry status
NA
Development phase
125
Enrollment target

NCT04371159 is a NA study that has completed, run by Healthy.io. The registered enrollment target is 125 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04371159, a NA study, has completed, sponsored by Healthy.io.

COMPLETED
Registry status
NA
Development phase
125 participants
Enrollment target

Study Summary

The Velieve U.S. UTI Urine Analysis Test System (henceforth Velieve U.S.) is composed of a kit and a smartphone application. The device will be provided to the subject in a simulated home-use environment. All subjects will be asked to complete the urine test by following the application guidance,including providing a urine sample and scanning the urine strip after placing it on the Color-Board. The user will also complete a questionnaire to collect information regarding the use of the Velieve U.S. device. Following the usability test performed by the lay user, the subject's urine sample will be tested by the professional user using the comparator device. The use of the Velieve U.S. device will be evaluated for identified risks. Additionally, measurable usability criteria for specific, critical steps will be evaluated.

Interventions

  • DEVICE Velieve U.S.

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2020-02-05
Est. Completion 2020-05-30
Phase NA

Sponsor

Healthy.io

7 total trials

What the Registry Record Tells You About NCT04371159

The ClinicalTrials.gov registry entry for NCT04371159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthy.io, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Velieve U.S. is the first listed.

NCT04371159 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04371159 about?

NCT04371159 is a clinical study titled "A Comparative, Controlled Study to Evaluate the Clinical Accuracy of the Velieve U.S. UTI Urine Analysis Test System". The Velieve U.S. UTI Urine Analysis Test System (henceforth Velieve U.S.) is composed of a kit and a smartphone application. The device will be provided to the subject in a simulated home-use environment. All subjects will be asked to complete the urine test by following the application guidance,inc...

What is the current status of trial NCT04371159?

This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2020-02-05. Estimated completion is 2020-05-30.

What interventions are being tested in trial NCT04371159?

The interventions under investigation include: Velieve U.S. (DEVICE).

Who is sponsoring clinical trial NCT04371159?

This trial is sponsored by Healthy.io, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.